OnCoCross Co Ltd (382150)

Currency in KRW
9,650.00
0.00(0.00%)
Closed·
382150 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
382150 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,500.009,750.00
52 wk Range
6,260.0016,700.00
Key Statistics
Bid/Ask
9,640.00 / 9,650.00
Prev. Close
9,650
Open
9,610
Day's Range
9,500-9,750
52 wk Range
6,260-16,700
Volume
58.27K
Average Volume (3m)
918.19K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
382150 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

OnCoCross Co Ltd Company Profile

Oncocross Co., Ltd. develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea. Its products pipeline includes OC101 for liver cirrhosis; OC101+OC111 for non-alcoholic steatohepatitis; OC201+OC202e for Inhibition of cancer metastasis; OC211, a Pan-KRAS Inhibitor; OC221, an immuno-oncology combination; OC514 to treat amyotrophic lateral sclerosis and Duchenne muscular dystrophy; and OC701 to treat atopic dermatitis. The company is also developing OJP3101 for metabolic disease; OJP3101 for Cardiovascular Disease; ODP9401 for metabolic disease; and ODP2201, ODP2301, and ODP2401 to treat oncology-related diseases. It has a collaboration agreement with various pharmaceutical companies, research institutes, and bio-techs. The company was founded in 2015 and is based in Seoul, South Korea.

Compare 382150 to Peers and Sector

Metrics to compare
382150
Peers
Sector
Relationship
P/E Ratio
−15.9x−4.6x−0.5x
PEG Ratio
1.20−0.110.00
Price/Book
6.3x2.5x2.6x
Price / LTM Sales
107.3x6.0x3.2x
Upside (Analyst Target)
-0.0%41.2%
Fair Value Upside
Unlock13.7%6.2%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-190.00 / --
Revenue / Forecast
62.57M / --
EPS Revisions
Last 90 days

382150 Income Statement

People Also Watch

65,100
034020
+2.52%
38,100
009830
0.00%
56,500
272210
-2.25%
25,200.00
476060
-0.40%
1,088,000
207940
+1.97%

FAQ

What Stock Exchange Does OnCoCross Trade On?

OnCoCross is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for OnCoCross?

The stock symbol for OnCoCross is "382150."

What Is the OnCoCross Market Cap?

As of today, OnCoCross market cap is 115.30B.

What Is OnCoCross's Earnings Per Share (TTM)?

The OnCoCross EPS (TTM) is -670.06.

From a Technical Analysis Perspective, Is 382150 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has OnCoCross Stock Split?

OnCoCross has split 0 times.

How Many Employees Does OnCoCross Have?

OnCoCross has 0 employees.

What is the current trading status of OnCoCross (382150)?

As of 29 Jul 2025, OnCoCross (382150) is trading at a price of 9,650.00, with a previous close of 9,650.00. The stock has fluctuated within a day range of 9,500.00 to 9,750.00, while its 52-week range spans from 6,260.00 to 16,700.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.